Is an elevated triglyceride-glucose (TyG) index associated with an increased risk of heart failure in patients with type 2 diabetes mellitus?
The TyG index may serve as a clinically accessible, cost-effective biomarker for early heart failure risk identification in patients with T2DM.
Elevated TyG index is independently associated with increased risk of HF in patients with T2DM. It may serve as a clinically accessible, cost-effective biomarker for early HF risk identification, particularly in high-risk subpopulations.
Yan et al. (Tue,) studied this question.